155 related articles for article (PubMed ID: 8639515)
1. Mutagenesis of transmembrane domain 11 of P-glycoprotein by alanine scanning.
Hanna M; Brault M; Kwan T; Kast C; Gros P
Biochemistry; 1996 Mar; 35(11):3625-35. PubMed ID: 8639515
[TBL] [Abstract][Full Text] [Related]
2. Contribution to substrate specificity and transport of nonconserved residues in transmembrane domain 12 of human P-glycoprotein.
Hafkemeyer P; Dey S; Ambudkar SV; Hrycyna CA; Pastan I; Gottesman MM
Biochemistry; 1998 Nov; 37(46):16400-9. PubMed ID: 9819232
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of P-glycoprotein mutants identifies predicted transmembrane domain 11 as a putative drug binding site.
Kajiji S; Talbot F; Grizzuti K; Van Dyke-Phillips V; Agresti M; Safa AR; Gros P
Biochemistry; 1993 Apr; 32(16):4185-94. PubMed ID: 7682843
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of the P-glycoprotein first intracellular loop and flanking transmembrane domains.
Kwan T; Gros P
Biochemistry; 1998 Mar; 37(10):3337-50. PubMed ID: 9521654
[TBL] [Abstract][Full Text] [Related]
5. Modulatory effects on substrate specificity of independent mutations at the serine939/941 position in predicted transmembrane domain 11 of P-glycoproteins.
Dhir R; Grizzuti K; Kajiji S; Gros P
Biochemistry; 1993 Sep; 32(36):9492-9. PubMed ID: 8103679
[TBL] [Abstract][Full Text] [Related]
6. The extracellular loop between TM5 and TM6 of P-glycoprotein is required for reactivity with monoclonal antibody UIC2.
Zhou Y; Gottesman MM; Pastan I
Arch Biochem Biophys; 1999 Jul; 367(1):74-80. PubMed ID: 10375401
[TBL] [Abstract][Full Text] [Related]
7. Cysteine-scanning mutagenesis provides no evidence for the extracellular accessibility of the nucleotide-binding domains of the multidrug resistance transporter P-glycoprotein.
Blott EJ; Higgins CF; Linton KJ
EMBO J; 1999 Dec; 18(23):6800-8. PubMed ID: 10581253
[TBL] [Abstract][Full Text] [Related]
8. Membrane topology of P-glycoprotein as determined by epitope insertion: transmembrane organization of the N-terminal domain of mdr3.
Kast C; Canfield V; Levenson R; Gros P
Biochemistry; 1995 Apr; 34(13):4402-11. PubMed ID: 7535563
[TBL] [Abstract][Full Text] [Related]
9. A single amino acid substitution strongly modulates the activity and substrate specificity of the mouse mdr1 and mdr3 drug efflux pumps.
Gros P; Dhir R; Croop J; Talbot F
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7289-93. PubMed ID: 1678520
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the nucleotide-binding sites of P-glycoprotein that affect substrate specificity modulate substrate-induced adenosine triphosphatase activity.
Beaudet L; Urbatsch IL; Gros P
Biochemistry; 1998 Jun; 37(25):9073-82. PubMed ID: 9636053
[TBL] [Abstract][Full Text] [Related]
11. Transmembrane organization of mouse P-glycoprotein determined by epitope insertion and immunofluorescence.
Kast C; Canfield V; Levenson R; Gros P
J Biol Chem; 1996 Apr; 271(16):9240-8. PubMed ID: 8621583
[TBL] [Abstract][Full Text] [Related]
12. [Structures and functions of xenobiotic efflux pump P-glycoprotein and MRP--important molecular targets for cancer chemotherapy].
Ueda K
Gan To Kagaku Ryoho; 1997 Dec; 24(15):2190-5. PubMed ID: 9422060
[TBL] [Abstract][Full Text] [Related]
13. Functional consequences of proline mutations in the predicted transmembrane domain of P-glycoprotein.
Loo TW; Clarke DM
J Biol Chem; 1993 Feb; 268(5):3143-9. PubMed ID: 8094081
[TBL] [Abstract][Full Text] [Related]
14. Functional role of the linker region in purified human P-glycoprotein.
Sato T; Kodan A; Kimura Y; Ueda K; Nakatsu T; Kato H
FEBS J; 2009 Jul; 276(13):3504-16. PubMed ID: 19490125
[TBL] [Abstract][Full Text] [Related]
15. The conserved tyrosine residues 401 and 1044 in ATP sites of human P-glycoprotein are critical for ATP binding and hydrolysis: evidence for a conserved subdomain, the A-loop in the ATP-binding cassette.
Kim IW; Peng XH; Sauna ZE; FitzGerald PC; Xia D; Müller M; Nandigama K; Ambudkar SV
Biochemistry; 2006 Jun; 45(24):7605-16. PubMed ID: 16768456
[TBL] [Abstract][Full Text] [Related]
16. Functional evidence that transmembrane 12 and the loop between transmembrane 11 and 12 form part of the drug-binding domain in P-glycoprotein encoded by MDR1.
Zhang X; Collins KI; Greenberger LM
J Biol Chem; 1995 Mar; 270(10):5441-8. PubMed ID: 7890659
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the role of polar amino acid residues within predicted transmembrane helix 17 in determining the substrate specificity of multidrug resistance protein 3.
Zhang DW; Gu HM; Vasa M; Muredda M; Cole SP; Deeley RG
Biochemistry; 2003 Aug; 42(33):9989-10000. PubMed ID: 12924948
[TBL] [Abstract][Full Text] [Related]
18. Functional consequences of phenylalanine mutations in the predicted transmembrane domain of P-glycoprotein.
Loo TW; Clarke DM
J Biol Chem; 1993 Sep; 268(27):19965-72. PubMed ID: 8104183
[TBL] [Abstract][Full Text] [Related]
19. Transmembrane helix 11 of multidrug resistance protein 1 (MRP1/ABCC1): identification of polar amino acids important for substrate specificity and binding of ATP at nucleotide binding domain 1.
Zhang DW; Nunoya K; Vasa M; Gu HM; Theis A; Cole SP; Deeley RG
Biochemistry; 2004 Jul; 43(29):9413-25. PubMed ID: 15260484
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of a tryptophan-less P-glycoprotein: a tool for tryptophan insertion and fluorescence spectroscopy.
Kwan T; Loughrey H; Brault M; Gruenheid S; Urbatsch IL; Senior AE; Gros P
Mol Pharmacol; 2000 Jul; 58(1):37-47. PubMed ID: 10860925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
